Search Within

Danielle Cohen Glassman

Formats
  1. Meeting Abstract (5)
  2. Journal Article (4)
Groups
  1. Center for Pancreatic Cancer Research (9)
  2. Department of Medicine (9)
  3. Gastrointestinal Oncology Service (9)
  4. Solid Tumor Oncology Division (9)
  5. Epidemiology and Biostatistics (5)
  6. GSK Faculty (4)

More Groups

People
  1. Kenneth Yu (9)
  2. Eileen O'Reilly (7)
  3. Christina Covington (6)
  4. James Harding (6)
  5. Ghassan Abou-Alfa (5)
  6. Maeve Lowery (5)

More People

Years
  1. 2021 (1)
  2. 2018 (3)
  3. 2017 (3)
  4. 2016 (2)
Publications
  1. Journal of Clinical Oncology (4)
  2. BMC Cancer (1)
  3. Cancer (1)
  4. Cancer Research (1)
  5. Clinical Cancer Research (1)
  6. Nature Communications (1)
Publishers
  1. American Society of Clinical Oncology (4)
  2. American Association for Cancer Research (2)
  3. Biomed Central Ltd (1)
  4. Nature Publishing Group (1)
  5. Wiley Blackwell (1)

Results (9)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pancreatic cancer prognosis is predicted by an ATAC-array technology for assessing chromatin accessibility
    Journal Article

    Dhara, S.; Chhangawala, S.; Chintalapudi, H.; Askan, G.; Aveson, V.; Massa, A. L.; Zhang, L.; Torres, D.; Makohon-Moore, A. P.; Lecomte, N.; more...
    Nature Communications (2021)

    Fulltext@MSK | Save
  • Genome wide cis-regulatory elements accessibility signature predicts early recurrence of the treatment-naïve resected subset of PDAC: A new paradigm for precision oncology
    Meeting Abstract

    Dhara, S.; Chhangawala, S.; Askan, G.; Liguo, Z.; Sinha, S.; Glassman, D.; Yu, K.; Balachandran, V.; Leslie, C.; Leach, S.
    Cancer Research (2018)

    Fulltext@MSK | Save
  • Nano-liposomal irinotecan and 5-FU/LV (N+F) for the treatment of advanced PDAC: Memorial Sloan Kettering (MSK) single cancer center evaluation
    Meeting Abstract

    Glassman, D. C.; Desai, A. M.; Ku, G. Y.; Li, J.; Harding, J. J.; Varghese, A. M.; O'Reilly, E. M.; Yu, K. H.
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Nanoliposomal irinotecan with fluorouracil for the treatment of advanced pancreatic cancer, a single institution experience
    Journal Article

    Glassman, D. C.; Palmaira, R. L.; Covington, C. M.; Desai, A. M.; Ku, G. Y.; Li, J.; Harding, J. J.; Varghese, A. M.; O'Reilly, E. M.; Yu, K. H.
    BMC Cancer (2018)

    Fulltext@MSK | Save
  • Phase IB trial of ADI-PEG 20 (A) plus nab-paclitaxel (nab-P) and gemcitabine (gem) in patients with advanced pancreatic cancer (PC)
    Meeting Abstract

    Lowery, M. A.; Harding, J. J.; Yu, K. H.; Kelsen, D. P.; Bomalaski, J. S.; Glassman, D. C.; Covington, C. M.; Brenner, R.; Hollywood, E.; Barba, A.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase 1/1B trial of ADI-PEG 20 plus nab-paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma
    Journal Article

    Lowery, M. A.; Yu, K. H.; Kelsen, D. P.; Harding, J. J.; Bomalaski, J. S.; Glassman, D. C.; Covington, C. M.; Brenner, R.; Hollywood, E.; Barba, A.; more...
    Cancer (2017)

    Fulltext@MSK | Save
  • Real-time genomic profiling of pancreatic ductal adenocarcinoma: Potential actionability and correlation with clinical phenotype
    Journal Article

    Lowery, M. A.; Jordan, E. J.; Basturk, O.; Ptashkin, R. N.; Zehir, A.; Berger, M. F.; Leach, T.; Herbst, B.; Askan, G.; Maynard, H.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • Phase 1B trial of ADI-PEG 20 (A) plus nab-paclitaxel (nab-P) and gemcitabine (gem) in subjects with advanced pancreatic cancer (APC)
    Meeting Abstract

    Lowery, M. A.; Capanu, M.; Glassman, D. C.; Covington, C. M.; Gluskin, J.; Brenner, R.; Li, C. F.; Bomalaski, J. S.; Johnston, A.; Barba, A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Genomic profiling of pancreas ductal adenocarcinoma (PDA), actionability, and correlation with clinical phenotype
    Meeting Abstract

    Jordan, E.; Lowery, M. A.; Ptashkin, R.; Zehir, A.; Berger, M. F.; Maynard, H.; Glassman, D. C.; Covington, C. M.; Schultz, N.; Abou-Alfa, G. K.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save